Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
Business Wire
Buoy Health Receives Robert Wood Johnson Foundation Artificial Intelligence Award for Patient Health Education
October 3, 2018 -
TraceLink Surpasses 1,000 Customer Milestone, Including Over 500 Pharmaceutical Manufacturing Companies
October 3, 2018 -
Centogene, Denali Therapeutics Partner to Recruit Parkinson’s Patients for Drug Program
October 3, 2018 -
FierceBiotech Names Compass Therapeutics a 2018 “Fierce 15” Biotech Company
October 2, 2018 -
Notable Health Named an IDC Innovator for Enterprise Wearable Software Solutions in Health Care
October 1, 2018 -
Modis Therapeutics Announces $30M Series A Financing
October 1, 2018 -
Pharmeasy raises $50 million in Series C funding
September 29, 2018 -
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-CD47 Monoclonal Antibody IBI-188
September 29, 2018 -
Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture
September 27, 2018 -
NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer
September 24, 2018 -
Innovent Presents Clinical Data of Anti-PD-1 Antibody Sintilimab in Patients with Previously Treated Non-Small Cell Lung Cancer at Annual Meeting of the Chinese Society of Clinical Oncology
September 21, 2018 -
b-ONE Ortho Receives U.S. FDA 510(k) Clearance for Total Hip System
September 21, 2018 -
CareStack™ Announces Completion of $16 Million Financing to Expand Cloud-Based Enterprise Platform for Dental Practices
September 21, 2018 -
Devoted Health Receives License from State of Florida
September 20, 2018 -
Hua Medicine Successfully Completes Initial Public Offering and Listing on the Hong Kong Stock Exchange
September 14, 2018 -
Iora Health and Humana Expand Relationship to Provide More Humana Medicare Advantage Plan Members Access to Improved Care in Arizona, Georgia and Washington
September 13, 2018 -
Innovent doses first patient in Phase III sintilimab trial for NSCLC
September 13, 2018 -
Gilead Sciences and Precision BioSciences Announce Collaboration to Develop Therapies Against Hepatitis B Virus Using ARCUS Genome Editing
September 12, 2018 -
Unum Therapeutics to Present at Morgan Stanley 16th Annual Global Healthcare Conference
September 10, 2018 -
Innovent’s Anti-CD47 Antibody IBI188 Receives IND Approval in China
September 10, 2018 -
Notable Health Closes $13.5 Million Series A Financing to Expand Artificial Intelligence Powered Physician-Patient Interaction Platform
September 6, 2018 -
Tempest Therapeutics Names Dr. Ginna Laport CMO
September 5, 2018 -
Checkmate Pharmaceuticals Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate Combination Therapy with CMP-001 and Avelumab
September 5, 2018 -
Precision BioSciences Announces Collaboration with University of Pennsylvania to Develop Genome Editing Therapeutics
September 5, 2018 -
Turnstone Biologics and the La Jolla Institute for Allergy and Immunology Enter into Strategic Collaboration for Personalized Neoantigen Immunotherapies
September 4, 2018 -
Surface Oncology to Present at the Baird 2018 Global Healthcare Conference
September 4, 2018 -
Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs
August 29, 2018 -
Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs
August 29, 2018 -
Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources
August 29, 2018 -
TraceLink, which helps pharma companies trace drugs through the supply chain, just raised $93 million
August 23, 2018 -
Orchard Therapeutics Announces $150 Million Series C Financing to Advance Gene Therapy Pipeline
August 13, 2018 -
Buoy Health Partners With Boston Children’s Hospital To Improve The Way Parents Currently Assess Their Children’s Symptoms Online
August 10, 2018 -
Protenus President to Discuss How Analytics Align Privacy and Security Vision to Reality
August 6, 2018 -
Denali Therapeutics Announces Positive Clinical Results From LRRK2 Inhibitor Program for Parkinson’s Disease
August 1, 2018 -
Innovent Receives IND Approval to Initiate Clinical Trials in China with its anti-OX40 Agonistic Antibody IBI101 and its anti-RANKL Antibody IBI307
July 27, 2018 -
TraceLink Adds More than 130 New Customers in Q2 2018 with 255 Companies Now Live in Production, Exchanging Serialized Product Data on the Life Sciences Cloud
July 24, 2018 -
Centivo, a New Type of Health Plan, Raises $34 Million in Series A Funding
July 18, 2018 -
Consumers Demand Patient Data Protection as Black Book Names Protenus as Leading-Edge Innovator
July 17, 2018 -
Compass Therapeutics Closes on Series A Financing Totaling $132 Million
July 12, 2018 -
TraceLink Unveils Product Information Manager, a Standards-Based Network Application for Its Industry-Leading Digital Information Sharing Platform
July 10, 2018 -
US FDA Approves Adagene IO program IND for Solid Tumor and Non-Hodgkin Lympoma Ph1 trial
July 9, 2018 -
Tracelink partners with IBI Lorenzini, as FMD deadline looms over Europe
July 3, 2018 -
UMMC Selects Kyruus’ ProviderMatch for Access Centers to Improve Call Center Operations
July 2, 2018 -
Biotech Startup Innovent Files for Hong Kong Debut
July 2, 2018 -
Orchard Therapeutics Appoints Jim Geraghty as Chairman of its Board of Directors
June 29, 2018 -
BurstIQ Blockchain Healthcare Company Partners with VitalWare For Business Expansion
June 29, 2018 -
University of Mississippi Medical Center (UMMC) to Utilize Kyruus Technology to Enhance Patient Access and Patient-Provider Matching
June 28, 2018 -
WelbeHealth Raises $15 Million Series B to Accelerate Growth of Innovative Care Programs for Seniors
June 28, 2018 -
Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs
June 26, 2018 -
Italian Pharmaceutical Manufacturer and CMO, IBI Lorenzini, Selects TraceLink to Comply with Global Serialization Regulations
June 26, 2018 -
BurstIQ Announces Partnership with VitalWare(TM), Bringing Blockchain to Healthcare Revenue Cycle Management
June 26, 2018 -
Surface Oncology Recognized as one of the “Best Places to Work” by Boston Business Journal
June 21, 2018 -
VitalWare™ Introduces Advanced Charge Auditing Capabilities within Existing VitalAuditor™ Tool
June 21, 2018 -
Iora Health Looks to ‘Kick the Industry in the Behind’
June 19, 2018 -
Benchling Raises $14.5M From Benchmark to Advance Life Sciences Research
June 14, 2018 -
PatientPing Partners with WISHIN to Advance Care Coordination Throughout Wisconsin
June 13, 2018 -
Denali Therapeutics and AbCellera Announce Collaboration to Discover New Antibodies to Treat Neurodegenerative Diseases
June 12, 2018 -
TraceLink Tracks Down $60M to Fight Counterfeit Drugs Worldwide
June 11, 2018 -
Hua Medicine Planning Hong Kong IPO
June 6, 2018 -
TraceLink Customers Receive EMVO Approval for Data Submission to EU Hub
June 6, 2018 -
Adaptimmune Announces First Patient to Receive One Billion Target Cell Dose after Positive Safety Data from Pilot Study with MAGE-A4 SPEAR T-cells
June 4, 2018 -
Circulation Teams Up with AI Powered Buoy Health to Bring On-Demand Transportation Options to Millions of Patients Online
May 24, 2018 -
Navigant, Lumere Collaborate to Help Healthcare Providers Target Clinical and Financial Variation
May 23, 2018 -
Turnstone Biologics listed in top 10 among Canada’s 50 most attractive VC companies
May 22, 2018 -
Iora Health Raises $100 Million in Series E Financing
May 21, 2018 -
Protenus Recognized as One of the Best Places to Work in Healthcare in 2018
May 18, 2018 -
Innovent Biologics Announces the Study Result of its Anti-PD-1 Antibody in Hodgkin Lymphoma
May 16, 2018 -
Turnstone Biologics Announces U.S. FDA Acceptance of IND for Immunotherapy Targeting HPV Positive Cancers
May 16, 2018 -
TraceLink Achieves 69% Overall Revenue Growth in Q1 2018, Including 270% Revenue Growth in EMEA
May 16, 2018 -
Beam Therapeutics Launched to Develop Harvard Base Editing Technology toward Precision Genetic Medicines
May 14, 2018 -
Semma Therapeutics Appoints Bastiano Sanna, Ph.D. as Chief Executive Officer and President
May 11, 2018 -
Ivenix to Showcase Patient-Centered Infusion System at NTI 2018
May 10, 2018 -
New England Venture Capital Association names 2018 NEVY Awards winners – Devoted Health named Healthcare IT Company of the Year
May 10, 2018 -
F-Prime Capital Partners Announces Parker Moss as New Entrepreneur-in-Residence
May 9, 2018 -
Buoy Health and CVS Health Provide Easy Access to Affordable Care
May 8, 2018 -
Science 2 Startup Symposium Convened Over 230 Academic Researchers, Venture Capitalists, Entrepreneurs, and Pharmaceutical Executives, Creating Connections that can Advance Scientific Innovation and Entrepreneurship
May 4, 2018 -
Orchard Therapeutics’ OTL-200 Receives Rare Pediatric Disease Designation from FDA for Treatment of Metachromatic Leukodystrophy
May 3, 2018 -
Lumere, AHVAP Announce Partnership to Highlight Best Practices in Managing Care Variation
May 1, 2018 -
Innovent Biologics completed US $150 million Series E round financing
April 26, 2018 -
Orchard Therapeutics Expands US Presence with New Corporate Office in Boston
April 24, 2018 -
David Rowan, Founding Editor-in-Chief of WIRED UK Magazine, to Deliver Opening Keynote on the Future of Digital Health at FutureLink Munich
April 24, 2018 -
Cytek Biosciences Spotlights the Cytek Aurora Flow Cytometry System at CYTO 2018
April 24, 2018 -
Checkmate Pharmaceuticals Announces Start of Phase 1b Trial of CMP-001 in Combination with Anti-PD-L1 Immunotherapy in Anti-PD-1/PD-L1 Resistant Advanced Non-Small Cell Lung Cancer
April 24, 2018 -
Kyruus Raises $10 Million to Fuel Continued Growth
April 18, 2018 -
Surface Oncology Announces $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement
April 18, 2018 -
Checkmate Pharmaceuticals Presents Clinical Data at the 2018 American Association for Cancer Research (AACR) Annual Meeting
April 17, 2018 -
Atlas Venture, F-Prime Capital Partners and SV Health Investors to Host Symposium Featuring Therapeutics Startup Ideas From World’s Top Academic Research Institutions
April 12, 2018 -
GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics
April 12, 2018 -
Acacia Pharma Expands US Commercial Operations for BAREMSIS® with Four Key Appointments
April 11, 2018 -
Acacia Pharma Expands US Commercial Operations for BAREMSIS® with Four Key Appointments
April 11, 2018
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.